ATE462791T1 - Parvovirus ns1 varianten - Google Patents

Parvovirus ns1 varianten

Info

Publication number
ATE462791T1
ATE462791T1 AT99115161T AT99115161T ATE462791T1 AT E462791 T1 ATE462791 T1 AT E462791T1 AT 99115161 T AT99115161 T AT 99115161T AT 99115161 T AT99115161 T AT 99115161T AT E462791 T1 ATE462791 T1 AT E462791T1
Authority
AT
Austria
Prior art keywords
parvovirus
variants
relates
dnas
variant
Prior art date
Application number
AT99115161T
Other languages
English (en)
Inventor
Juerg Nueesch
Jean Rommelaere
Original Assignee
Deutsches Krebsforsch
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Deutsches Krebsforsch filed Critical Deutsches Krebsforsch
Application granted granted Critical
Publication of ATE462791T1 publication Critical patent/ATE462791T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14311—Parvovirus, e.g. minute virus of mice
    • C12N2750/14322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT99115161T 1999-08-13 1999-08-13 Parvovirus ns1 varianten ATE462791T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99115161A EP1077260B1 (de) 1999-08-13 1999-08-13 Parvovirus NS1 Varianten

Publications (1)

Publication Number Publication Date
ATE462791T1 true ATE462791T1 (de) 2010-04-15

Family

ID=8238701

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99115161T ATE462791T1 (de) 1999-08-13 1999-08-13 Parvovirus ns1 varianten

Country Status (6)

Country Link
US (1) US6919196B1 (de)
EP (1) EP1077260B1 (de)
AT (1) ATE462791T1 (de)
DE (1) DE69942200D1 (de)
ES (1) ES2343394T3 (de)
WO (1) WO2001012666A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1473306A1 (de) 2003-04-30 2004-11-03 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Als cytotoxin geeignetes fusionspolypeptid
ITRM20040561A1 (it) 2004-11-11 2005-02-11 Sigma Tau Ind Farmaceuti Uso della acetil l-carnitina in combinazione con propionil l-carnitina e sildenafil per il trattamento della disfunzione erettile.
US20110014723A1 (en) * 2008-03-14 2011-01-20 Erdman Dean D Compositions and processes relating to human bocavirus
EP2384761B1 (de) * 2010-05-07 2013-09-04 Deutsches Krebsforschungszentrum Modifiziertes Nagetier-Parvovirus, das sich durch menschliche Glioma vermehren und ausbreiten kann
EP2404609A1 (de) 2010-07-07 2012-01-11 Deutsches Krebsforschungszentrum Verwendung vom Parvovirus zur Beseitigung von Krebsstammzellen
TW202336236A (zh) * 2015-03-27 2023-09-16 美商再生元醫藥公司 偵測生物污染物之組成物及方法
EP3738972A1 (de) 2019-05-13 2020-11-18 Deutsches Krebsforschungszentrum Parvolysin

Also Published As

Publication number Publication date
EP1077260A1 (de) 2001-02-21
EP1077260B1 (de) 2010-03-31
WO2001012666A1 (en) 2001-02-22
US6919196B1 (en) 2005-07-19
ES2343394T3 (es) 2010-07-29
DE69942200D1 (de) 2010-05-12

Similar Documents

Publication Publication Date Title
ATE445376T1 (de) Schraube zur befestigung der wirbelsäule
AP2212A (en) Phosphonates, Monophosphonamidates, Bisphosphonamidates for the treatment of viral diseases.
MXPA03010909A (es) Derivados de epotilona.
DE60236367D1 (de) Echolöscher, der eine weitere reduktion des restechos sicherstellt
HUP0101594A2 (hu) Parathormon alkalmazása csontkeménység és csontszilárdság növelésére, valamint csonttörések csökkentésére
ZA200702523B (en) Process for the purification of 1,4-butanediol
NO20050091L (no) Fremgangsmater for fremstilling av fibrinogen
DK1264603T3 (da) Anvendelse af L-polynukleotider til in vivo-billeddannelse
MXPA03009478A (es) Mezclas con resistencia al impacto modificada de poli (tereftalato de etileno) y al menos un policarbonato basado en dihidroxidiarilciclohexano.
BR0108826B1 (pt) processo para a produção de uma zeólita contendo titánio, zeólita contendo titánio assim obtida, processo para a epoxidação de olefinas e uso da referida zeólita.
WO2002081745A3 (en) Genes involved in osteogenesis, and methods of use
ATE462791T1 (de) Parvovirus ns1 varianten
DK1383742T3 (da) Syntese og fremgangsmåder til anvendelse af tetrahydroindolonanaloge og derivater
BR0115991A (pt) Processo para o isolamento e a purificação de epotilonas
NO20014241D0 (no) C16-umettede FP-selektive prostaglandinanaloger
ITGE20020050A0 (it) Procedimento per il trattamento di filati mediante agugliatura.
MXPA04004090A (es) Compuestos substituidos de 1h-quinolin-2-ona.
WO2002024181A3 (en) The use of melatonin for induction of general anesthesia
AU2003227593A1 (en) New analogs of nitrobenzylthioinosine
PL1627881T3 (pl) Sposób otrzymywania topiramatu
PL1612210T3 (pl) Nowe analogi nitrobenzylotioinozyny
ATE345818T1 (de) S-methyl-dihydro-ziprasidone zur behandlung von psychiatrischen störungen.
BR0210678A (pt) Carbamatos de 2-heterocìclicos-1,2-etanodióis
WO1999053091A3 (de) Gdnf-kodierende dna, teile davon und gdnf-varianten
ATE342280T1 (de) Menschliche promotoren des gaba b-rezeptors 1

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1077260

Country of ref document: EP